{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T07:49:24Z","timestamp":1790495364985,"version":"4.1.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,11,13]]},"DOI":"10.1097\/qad.0b013e32833ed2a7","type":"journal-article","created":{"date-parts":[[2010,8,27]],"date-time":"2010-08-27T11:12:43Z","timestamp":1282907563000},"page":"2651-2656","source":"Crossref","is-referenced-by-count":15,"title":["Resistance analyses in highly experienced patients failing raltegravir, etravirine and darunavir\/ritonavir regimen"],"prefix":"10.1097","volume":"24","author":[{"given":"Charlotte","family":"Charpentier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Roquebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Colin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Taburet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Fagard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Katlama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Jacomet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Brun-V\u00e9zinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve","family":"Ch\u00eane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazdan","family":"Yazdanpanah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Descamps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210130","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMoa0708975","article-title":"Raltegravir with optimized background therapy for resistant HIV-1 infection","volume":"359","author":"Steigbigel","year":"2008","journal-title":"N Engl J Med"},{"key":"R2-7-20210130","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(07)61048-4","article-title":"Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial","volume":"370","author":"Lazzarin","year":"2007","journal-title":"Lancet"},{"key":"R3-7-20210130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(07)61047-2","article-title":"Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial","volume":"370","author":"Madruga","year":"2007","journal-title":"Lancet"},{"key":"R4-7-20210130","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0140-6736(07)60497-8","article-title":"Efficacy and safety of darunavir\u2013ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials","volume":"369","author":"Clotet","year":"2007","journal-title":"Lancet"},{"key":"R5-7-20210130","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1086\/630210","article-title":"High rate of virologic suppression with raltegravir plus etravirine and darunavir\/ritonavir among treatment-experienced patients infected with multidrug-resistant HIV: results of the ANRS 139 TRIO trial","volume":"49","author":"Yazdanpanah","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R6-7-20210130","first-page":"125","article-title":"Update of the drug resistance mutations in HIV-1: Fall 2006","volume":"14","author":"Johnson","year":"2006","journal-title":"Top HIV Med"},{"key":"R7-7-20210130","first-page":"119","article-title":"Update of the drug resistance mutations in HIV-1: 2004","volume":"12","author":"Johnson","year":"2004","journal-title":"Top HIV Med"},{"key":"R8-7-20210130","first-page":"138","article-title":"Update of the drug resistance mutations in HIV-1: December 2009","volume":"17","author":"Johnson","year":"2009","journal-title":"Top HIV Med"},{"key":"R9-7-20210130","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jchromb.2009.10.029","article-title":"Quantification of raltegravir (MK0518) in human plasma by high-performance liquid chromatography with photodiode array detection","volume":"878","author":"Goldwirt","year":"2010","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R10-7-20210130","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3109\/00365541003621502","article-title":"Raltegravir as functional monotherapy leads to virological failure and drug resistance in highly treatment-experienced HIV-infected patients.","volume":"42","author":"Caby","year":"2010","journal-title":"Scand J Infect Dis"},{"key":"R12-7-20210130","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0140-6736(09)62041-9","article-title":"Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials.","volume":"375","author":"Eron","year":"2010","journal-title":"Lancet"},{"key":"R13-7-20210130","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1097\/00002030-200006160-00017","article-title":"Absence of zidovudine resistance in antiretroviral-naive patients following zidovudine\/lamivudine\/protease inhibitor combination therapy: virological evaluation of the AVANTI2 and AVANTI 3 studies","volume":"14","author":"Maguire","year":"2000","journal-title":"AIDS"},{"key":"R14-7-20210130","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1086\/380509","article-title":"Incidence of resistance in a double-blind study comparing lopinavir\/ritonavir plus stavudine and lamivudine tonelfinavir plus stavudine and lamivudine","volume":"189","author":"Kempf","year":"2004","journal-title":"J Infect Dis"},{"key":"R15-7-20210130","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1097\/QAD.0b013e32832cbcec","article-title":"Characterization of virologic failure patients on darunavir\/ritonavir in treatment-experienced patients","volume":"23","author":"De Meyer","year":"2009","journal-title":"AIDS"},{"key":"R16-7-20210130","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/QAD.0b013e328336ac2a","article-title":"Etravirine limits the emergence of darunavir and other protease inhibitor resistance-associated mutations in the DUET trials","volume":"24","author":"Peeters","year":"2010","journal-title":"AIDS"},{"key":"R19-7-20210130","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/jac\/dkq099","article-title":"HIV-1 resistance patterns to integrase inhibitors in antiretroviral-experienced patients with virological failure on raltegravir-containing regimens","volume":"65","author":"da Silva","year":"2010","journal-title":"J Antimicrob Chemother"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002030-201011130-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:35:58Z","timestamp":1786041358000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-201011130-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,13]]},"references-count":16,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e32833ed2a7","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11,13]]}}}